TrialArthritis & rheumatology (Hoboken, N.J.)2022

Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis.

Paul Brogan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.